Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Walgreens Boots Alliance, Inc. (WBA) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Walgreens Boots Alliance, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1618921.
Total stock buying since 2014: $405,819,382.
Total stock sales since 2014: $764,558,917.
Total stock option exercises since 2014: $8,177,264.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2024 | 23,456 | $512,642 | 15,209 | $350,567 | 0 | $0 |
2023 | 15,172 | $486,493 | 1,000 | $20,450 | 0 | $0 |
2022 | 0 | $0 | 26,873 | $1,075,035 | 10,303 | $350,714 |
2021 | 0 | $0 | 2,725 | $128,497 | 0 | $0 |
2020 | 0 | $0 | 5,000 | $207,725 | 2,539 | $0 |
2019 | 18,000 | $982,080 | 469,678 | $26,730,083 | 0 | $0 |
2018 | 3,496,296 | $226,775,364 | 1,875,524 | $122,210,933 | 8,235 | $551,827 |
2017 | 147,350 | $11,589,668 | 8,208 | $637,624 | 0 | $0 |
2016 | 2,010,000 | $163,630,000 | 6,306,662 | $489,135,886 | 148,290 | $5,377,112 |
2015 | 21,500 | $1,843,135 | 1,495,947 | $123,280,903 | 53,214 | $1,897,611 |
2014 | 0 | $0 | 10,184 | $781,214 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2024-04 | 9,000 | $170,430 | 0 | $0 | 0 | $0 |
2024-01 | 14,456 | $342,212 | 15,209 | $350,567 | 0 | $0 |
2023-11 | 0 | $0 | 1,000 | $20,450 | 0 | $0 |
2023-06 | 5,172 | $146,983 | 0 | $0 | 0 | $0 |
2023-03 | 10,000 | $339,510 | 0 | $0 | 0 | $0 |
2022-11 | 0 | $0 | 26,873 | $1,075,035 | 10,303 | $350,714 |
2021-11 | 0 | $0 | 2,725 | $128,497 | 0 | $0 |
2020-11 | 0 | $0 | 5,000 | $207,725 | 0 | $0 |
2020-09 | 0 | $0 | 0 | $0 | 2,539 | $0 |
2019-11 | 0 | $0 | 234,355 | $14,801,861 | 0 | $0 |
2019-08 | 0 | $0 | 215,323 | $10,867,222 | 0 | $0 |
2019-05 | 0 | $0 | 20,000 | $1,061,000 | 0 | $0 |
2019-04 | 18,000 | $982,080 | 0 | $0 | 0 | $0 |
2018-11 | 0 | $0 | 21,756 | $1,728,213 | 8,235 | $551,827 |
2018-10 | 0 | $0 | 52,000 | $4,102,436 | 0 | $0 |
2018-08 | 0 | $0 | 2,736 | $180,548 | 0 | $0 |
2018-07 | 3,397,438 | $219,255,236 | 1,697,438 | $108,500,236 | 0 | $0 |
2018-05 | 0 | $0 | 2,736 | $179,372 | 0 | $0 |
2018-01 | 98,858 | $7,520,128 | 98,858 | $7,520,128 | 0 | $0 |
2017-11 | 0 | $0 | 2,736 | $184,324 | 0 | $0 |
2017-10 | 22,750 | $1,531,983 | 0 | $0 | 0 | $0 |
2017-07 | 0 | $0 | 2,736 | $218,305 | 0 | $0 |
2017-05 | 0 | $0 | 2,736 | $234,995 | 0 | $0 |
2017-02 | 124,600 | $10,057,685 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-04-11 | Bhandari Inderpal S (Director) | Buy | 3,000 | 18.05 | 54,150 |
2024-04-02 | Mahajan Manmohan (EVP and Global CFO) | Buy | 6,000 | 19.38 | 116,280 |
2024-01-29 | Jarrett Valerie B (Director) | Buy | 4,456 | 22.44 | 99,992 |
2024-01-16 | Schlichting Nancy M (Director) | Sale | 15,209 | 23.05 | 350,567 |
2024-01-05 | Wentworth Timothy C (Chief Executive Officer) | Buy | 10,000 | 24.22 | 242,220 |
2023-11-10 | Gates Richard P. (SVP, Chief Pharmacy Officer) | Sale | 1,000 | 20.45 | 20,450 |
2023-06-30 | Driscoll John Patrick (EVP, Pres. U.S. Healthcare) | Buy | 5,172 | 28.42 | 146,983 |
2023-03-29 | Brewer Rosalind G (CEO) | Buy | 10,000 | 33.95 | 339,510 |
2022-11-18 | Ban Kevin M. (EVP, Chief Medical Officer) | Sale | 10,303 | 40.19 | 414,108 |
2022-11-18 | Ban Kevin M. (EVP, Chief Medical Officer) | Option Ex | 10,303 | 34.04 | 350,714 |
2022-11-17 | Schlichting Nancy M | Sale | 16,570 | 39.89 | 660,927 |
2021-11-19 | Schlichting Nancy M | Sale | 2,725 | 47.16 | 128,497 |
2020-11-11 | Pagni Marco Patrick Anthony (EVP, Global CAO and GC) | Sale | 5,000 | 41.55 | 207,725 |
2020-09-01 | Dixon Heather Brianne (SVP, Global Controller and CAO) | Option Ex | 2,539 | .00 | 0 |
2019-11-05 | Pagni Marco Patrick Anthony (EVP, Global CAO and GC) | Sale | 234,355 | 63.16 | 14,801,861 |
2019-08-15 | Pagni Marco Patrick Anthony (EVP, Global CAO and GC) | Sale | 123,496 | 50.06 | 6,182,209 |
2019-08-14 | Pagni Marco Patrick Anthony (EVP, Global CAO and GC) | Sale | 91,827 | 51.02 | 4,685,013 |
2019-05-09 | Pagni Marco Patrick Anthony (EVP, Global CAO and GC) | Sale | 20,000 | 53.05 | 1,061,000 |
2019-04-03 | Barra Ornella (Co-Chief Operating Officer) | Buy | 18,000 | 54.56 | 982,080 |
2018-11-20 | Schlichting Nancy M (Director) | Sale | 7,050 | 78.81 | 555,610 |
2018-11-01 | Scardino Kimberly R (SVP, Global Controller and CAO) | Sale | 11,970 | 79.80 | 955,146 |
2018-11-01 | Scardino Kimberly R (SVP, Global Controller and CAO) | Option Ex | 8,235 | 67.01 | 551,827 |
2018-11-01 | Foote William C (Director) | Sale | 2,736 | 79.48 | 217,457 |
2018-10-31 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Sale | 52,000 | 78.89 | 4,102,436 |
2018-08-02 | Foote William C (Director) | Sale | 2,736 | 65.99 | 180,548 |
2018-07-16 | Barra Ornella (Co-Chief Operating Officer) | Buy | 1,700,000 | 65.15 | 110,755,000 |
2018-07-16 | Barra Ornella (Co-Chief Operating Officer) | Sale | 1,697,438 | 63.92 | 108,500,236 |
2018-07-16 | Pessina Stefano (Executive Vice Chairman, CEO) | Buy | 1,697,438 | 63.92 | 108,500,236 |
2018-05-02 | Foote William C (Director) | Sale | 2,736 | 65.56 | 179,372 |
2018-01-15 | Pessina Stefano (Executive Vice Chairman, CEO) | Buy | 98,858 | 76.07 | 7,520,128 |
2018-01-15 | Pessina Stefano (Executive Vice Chairman, CEO) | Sale | 98,858 | 76.07 | 7,520,128 |
2017-11-02 | Foote William C (Director) | Sale | 2,736 | 67.37 | 184,324 |
2017-10-26 | Babiak Janice M. (Director) | Buy | 600 | 69.64 | 41,784 |
2017-10-26 | Lederer John Anthony (Director) | Buy | 20,000 | 67.00 | 1,340,000 |
2017-10-26 | Graham Ginger L (Director) | Buy | 2,150 | 69.86 | 150,199 |
2017-07-25 | Foote William C (Director) | Sale | 2,736 | 79.79 | 218,305 |
2017-05-03 | Foote William C (Director) | Sale | 2,736 | 85.89 | 234,995 |
2017-02-07 | Barra Ornella (Co-Chief Operating Officer) | Buy | 124,000 | 80.72 | 10,009,280 |
2017-02-02 | Babiak Janice M. (Director) | Buy | 600 | 80.67 | 48,405 |
2016-11-28 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Sale | 5,700 | 85.05 | 484,785 |
2016-11-28 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Option Ex | 5,700 | 35.50 | 202,350 |
2016-11-18 | Murphy Ken (EVP, Chief Commercial Officer) | Sale | 102,172 | 83.23 | 8,503,775 |
2016-11-04 | Pessina Stefano (Executive Vice Chairman, CEO) | Buy | 2,000,000 | 81.41 | 162,820,000 |
2016-11-02 | Foote William C (Director) | Sale | 2,067 | 81.30 | 168,047 |
2016-09-08 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Sale | 23,996 | 85.00 | 2,039,660 |
2016-09-08 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Option Ex | 23,996 | 35.58 | 853,657 |
2016-07-26 | Foote William C (Director) | Sale | 2,067 | 81.35 | 168,150 |
2016-07-14 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Sale | 29,695 | 83.00 | 2,464,685 |
2016-07-14 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Option Ex | 29,695 | 35.58 | 1,056,399 |
2016-07-08 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Sale | 29,695 | 81.00 | 2,405,146 |
2016-07-08 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Option Ex | 29,695 | 35.58 | 1,056,399 |
2016-06-10 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Sale | 29,603 | 83.13 | 2,460,897 |
2016-06-10 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Option Ex | 29,603 | 37.30 | 1,104,191 |
2016-05-16 | Jana Partners Llc | Sale | 6,000,000 | 77.29 | 463,740,000 |
2016-04-21 | Foote William C (Director) | Sale | 2,066 | 80.99 | 167,325 |
2016-04-15 | Fairweather George Rollo (EVP and Global CFO) | Sale | 50,000 | 81.52 | 4,076,000 |
2016-03-17 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Sale | 13,728 | 83.01 | 1,139,561 |
2016-03-17 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Option Ex | 13,728 | 37.30 | 512,054 |
2016-03-09 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Sale | 15,873 | 83.03 | 1,317,855 |
2016-03-09 | Wilson-thompson Kathleen (EVP and Global Chief HRO) | Option Ex | 15,873 | 37.30 | 592,062 |
2016-01-12 | Lederer John Anthony (Director) | Buy | 10,000 | 81.00 | 810,000 |
2015-11-20 | Jana Partners Llc | Sale | 940,144 | 82.53 | 77,594,785 |
2015-11-19 | Jana Partners Llc | Sale | 512,326 | 82.67 | 42,353,990 |
2015-11-04 | Foote William C (Director) | Sale | 3,500 | 88.36 | 309,260 |
2015-11-02 | Lederer John Anthony (Director) | Buy | 10,000 | 84.88 | 848,800 |
2015-07-28 | Schaeffer Leonard D (Director) | Buy | 1,500 | 96.25 | 144,375 |
2015-07-16 | Foote William C (Director) | Sale | 3,500 | 94.95 | 332,325 |
2015-04-29 | Lederer John Anthony (Director) | Buy | 10,000 | 85.00 | 849,960 |
2015-01-29 | Sabatino Thomas J Jr (EVP, Global CLO and CAO) | Sale | 36,477 | 73.76 | 2,690,543 |
2015-01-29 | Sabatino Thomas J Jr (EVP, Global CLO and CAO) | Option Ex | 53,214 | 35.66 | 1,897,611 |
2014-12-29 | Gourlay Alexander W. (EVP and President of Walgreens) | Sale | 10,184 | 76.71 | 781,214 |
Insider trading activities including stock purchases, stock sales, and option exercises of WBA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Walgreens Boots Alliance, Inc. (symbol WBA, CIK number 1618921) see the Securities and Exchange Commission (SEC) website.